What should be monitored for a resident who has started a beta-blocker and experiences wheezing?

Monitoring the respiratory status of a resident who has started a beta-blocker and is experiencing wheezing is crucial because beta-blockers can potentially cause bronchoconstriction, particularly in individuals with a history of respiratory issues such as asthma or chronic obstructive pulmonary disease (COPD). Wheezing is a sign of compromised airway and lung function, indicating that the individual may be struggling to breathe properly.

By closely observing the respiratory status, caregivers can assess the adequacy of the resident's airway, ability to ventilate, and oxygenation levels indirectly. This monitoring includes checking for changes in breathing patterns, use of accessory muscles, respiratory rate, and any changes in the intensity of wheezing. Early identification of worsening respiratory issues can lead to timely medical intervention, ensuring the safety and well-being of the resident.

While monitoring heart rate, oxygen levels, and blood pressure are essential components of overall patient care, the immediate concern in this scenario is the resident's respiratory health, making respiratory status the priority in this situation.